Literature DB >> 24714458

Leptin therapy gains FDA approval.

Gunjan Sinha.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24714458     DOI: 10.1038/nbt0414-300b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

Authors:  I S Farooqi; S A Jebb; G Langmack; E Lawrence; C H Cheetham; A M Prentice; I A Hughes; M A McCamish; S O'Rahilly
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

2.  Congenital leptin deficiency is associated with severe early-onset obesity in humans.

Authors:  C T Montague; I S Farooqi; J P Whitehead; M A Soos; H Rau; N J Wareham; C P Sewter; J E Digby; S N Mohammed; J A Hurst; C H Cheetham; A R Earley; A H Barnett; J B Prins; S O'Rahilly
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

3.  Leptin-replacement therapy for lipodystrophy.

Authors:  Elif Arioglu Oral; Vinaya Simha; Elaine Ruiz; Alexa Andewelt; Ahalya Premkumar; Peter Snell; Anthony J Wagner; Alex M DePaoli; Marc L Reitman; Simeon I Taylor; Phillip Gorden; Abhimanyu Garg
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

4.  Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.

Authors:  I Shimomura; R E Hammer; J A Richardson; S Ikemoto; Y Bashmakov; J L Goldstein; M S Brown
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

5.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

  5 in total
  5 in total

1.  Novo sets sights on obesity market with diabetes drug.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2014-11       Impact factor: 54.908

Review 2.  Renaissance of leptin for obesity therapy.

Authors:  Carmelo Quarta; Miguel A Sánchez-Garrido; Matthias H Tschöp; Christoffer Clemmensen
Journal:  Diabetologia       Date:  2016-03-16       Impact factor: 10.122

Review 3.  Adipose tissue in 2016: Advances in the understanding of adipose tissue biology.

Authors:  Shingo Kajimura
Journal:  Nat Rev Endocrinol       Date:  2017-01-04       Impact factor: 43.330

4.  The Spectrum of Genetic Variants Associated with the Development of Monogenic Obesity in Qatar.

Authors:  Nadien AbouHashem; Roan E Zaied; Kholoud Al-Shafai; Mariam Nofal; Najeeb Syed; Mashael Al-Shafai
Journal:  Obes Facts       Date:  2022-01-13       Impact factor: 4.807

Review 5.  New advances in the treatment of generalized lipodystrophy: role of metreleptin.

Authors:  Alexander J Rodriguez; Claudio A Mastronardi; Gilberto J Paz-Filho
Journal:  Ther Clin Risk Manag       Date:  2015-09-16       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.